Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Novita Pharmaceuticals, Inc., explained in plain language.
This study is testing whether adding an experimental drug called NP-G2-044 (Prilukae) to standard chemotherapy (PLD) works better than the standard chemo alone for women with platinum-resistant ovarian cancer. The goal is to find the best dose of the new combination and see if it…
Phase: PHASE2, PHASE3 • Sponsor: Novita Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC